IMPELLA CP PUMP SET 0048-0003

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-08-17 for IMPELLA CP PUMP SET 0048-0003 manufactured by Abiomed Europe, Gmbh (germany).

Event Text Entries

[53446087] The impella cp has not yet been returned for evaluation as it is currently being held in the complainant's risk management department; consequently, no device analysis could be performed. Upon the release and return of the device an evaluation will be performed and the results and conclusions will be reported in a supplemental medwatch report. (b)(4). Held in user's risk management department.
Patient Sequence No: 1, Text Type: N, H10


[53446088] The complainant reported that on (b)(6) 2016 a (b)(6) male patient presented at the hospital with a totally occluded right coronary artery (rca) and left anterior descending coronary artery (lad). The patient's left main (lm) was also found to be diseased. An impella cp was placed to allow hemodynamic support to the patient during stenting. Following successful stenting of the lm and lad, the rca was opened, but only one stent was able to be applied to the rc. The physician was unable to fully complete the repair of the rca, as radiation usage was reported to have become too high. The patient was then transferred to the intensive care unit (icu) and was reported to be doing well with the impella cp support successfully continued. The patient was administered heparin and integrin, blood seepage was then observed around the repositioning sheath and the right angioseal site. A femstop was then applied and the seepage was resolved. After over 22 hours of successful support the patient was reported to have been both looking and feeling better. It was then decided to remove the impella cp. During explant of the device the pump cannula separated into 2 pieces. The separated portion was able to be retrieved by hand at the femoral insertion site after the application of slight pressure to the surrounding tissue. Following removal of the impella pump hemostasis was obtained. There were no adverse effects to the patient and the patient was reported to be in stable condition following the removal of the impella cp.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1220648-2016-00021
MDR Report Key5883961
Date Received2016-08-17
Date of Report2016-07-19
Date of Event2016-07-19
Date Facility Aware2016-07-19
Report Date2016-07-19
Date Reported to Mfgr2016-07-19
Date Mfgr Received2016-07-19
Device Manufacturer Date2016-07-11
Date Added to Maude2016-08-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. WILLIAM BOLT
Manufacturer StreetABIOMED, INC. 22 CHERRY HILL DRIVE
Manufacturer CityDANVERS MA 01923
Manufacturer CountryUS
Manufacturer Postal01923
Manufacturer Phone9786461451
Manufacturer G1ABIOMED EUROPE, GMBH (GERMANY)
Manufacturer StreetNEUEHOFER WEG 3
Manufacturer CityAACHEN, GERMANY 13059, GM
Manufacturer CountryGM
Manufacturer Postal Code13059, GM
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameIMPELLA CP PUMP SET
Generic NameTEMPORARY CARDIAC SUPPORT BLOOD PUMP
Product CodePBL
Date Received2016-08-17
Model Number0048-0003
Catalog Number0048-0003
Lot Number1241332
Device Expiration Date2018-01-31
OperatorPHYSICIAN
Device AvailabilityN
Device Age8 DA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABIOMED EUROPE, GMBH (GERMANY)
Manufacturer AddressNEUEHOFER WEG 3 AACHEN, GERMANY 13059, GM GM 13059, GM


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-08-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.